Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TresMonet is a luxury skincare and wellness company that utilizes proprietary molecular technology to combine high-potency CBD with plant-based stem cells. The company's platform focuses on enhancing the absorption and efficacy of active ingredients for skin rejuvenation and anti-inflammatory benefits. Their product line includes serums, facial creams, and body treatments designed for the luxury cosmeceutical market. TresMonet's technology aims to bridge the gap between traditional skincare and advanced biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TresMonet.